Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
67%
Ph phase_2
1
33%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
2(66.7%)
Phase 2Efficacy & side effects
1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Completed(2)
Terminated(1)

Detailed Status

Completed2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (66.7%)
Phase 21 (33.3%)

Trials by Status

completed267%
withdrawn133%

Recent Activity

0 active trials
Showing 3 of 3
completedphase_1

A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV

NCT05779995
withdrawnphase_2

Safety and Efficacy of Inhaled XW001 For Hospitalized COVID-19 Patients Requiring Oxygen Therapy

NCT05083117
completedphase_1

A Study of XW001 in Healthy Adult Subjects

NCT05642403

Clinical Trials (3)

Showing 3 of 3 trials
NCT05779995Phase 1

A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV

Completed
NCT05083117Phase 2

Safety and Efficacy of Inhaled XW001 For Hospitalized COVID-19 Patients Requiring Oxygen Therapy

Withdrawn
NCT05642403Phase 1

A Study of XW001 in Healthy Adult Subjects

Completed

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3